Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > バイオシミラー

Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO) (HY276016)

Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)
価格(USD):
スペック:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

  • SDS

概要
カタログ番号HY276016
説明
Tacatuzumab (HY276016) is a research-grade recombinant antibody targeting Alpha-fetoprotein. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
種反応性Human
アプリケーションELISA, Bioactivity: FACS, Functional assay, Research in vivo
宿主種Human
クローン性Monoclonal
アイソタイプIgG1-kappa
発現システム Mammalian cells
ターゲット Alpha-fetoprotein, Alpha-1-fetoprotein, Alpha-fetoglobulin, AFP, HPAFP
エンドトキシンレベル < 10 EU/mg
純度 >95% purity as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 P02771
形態 Liquid
保存バッファー 0.01M PBS pH 7.4

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
背景

Alpha-fetoprotein (AFP) is a ~68 kDa protein. Binds copper, nickel, and fatty acids as well as, and bilirubin less well than, serum albumin. Only a small percentage (less than 2%) of the human AFP shows estrogen-binding properties.

注意事項 For research use only. Not suitable for clinical or therapeutic use.
Isotype Control Human IgG1 Recombinant Isotype Control Antibody (13R4) (HV080507)
イメージ
  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    SEC-HPLC

    SEC-HPLC detection for Research Grade Tacatuzumab.

  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    Bioactivity

    Detects AFP/Alpha-fetoprotein in indirect ELISAs.

  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    SDS-PAGE

    SDS-PAGE for Research Grade Tacatuzumab.

  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    Flow CytoMetry

    Flow-cytometry using APC anti-human AFP antibody. HepG-2 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an APC anti-human AFP monoclonal antibody (Catalog: HY276016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    Flow CytoMetry

    Flow-cytometry using PE anti-human AFP antibody. HepG-2 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an PE anti-human AFP monoclonal antibody (Catalog: HY276016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    Flow CytoMetry

    Flow-cytometry using FITC anti-human AFP antibody. HepG-2 cells were fixed and permeabilized, then stained with an irrelevant antibody (Blue Histogram) or an FITC anti-human AFP monoclonal antibody (Catalog: HY276016, Yellow Histogram) at a concentration of 5 µg/ml for 30 mins at RT. After washing, cells analysed on a NovoCyte Flow Cytometer.

  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    Western blot

    Western blot analysis was performed using anti-AFP/Alpha-fetoprotein monoclonal antibody at 1ug/mL on various samples.
    Lane 1: recombinant human AFP/Alpha-fetoprotein (Catalog No: HY276011)
    Lane 2: negative control

  • Anti-Human alpha-Fetoprotein/AFP Reference Antibody (Tacatuzumab, RUO)

    Immunofluorescence

    Immunofluorescence staining of HepG2 with Human monoclonal antibody (20ug/ml, overnight at 4°C), followed by Alexa Fluor-488-conjugated secondary antibody (6.5ug/ml, 50minutes at room temperature). The target protein was detected in the cytoplasm.

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: [email protected]

ディストリビューターリスト